Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Faber F et al. | Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. | 2016 | Nature | pmid:27309805 |
Gemici C et al. | Is there any role of intravenous iron for the treatment of anemia in cancer? | 2016 | BMC Cancer | pmid:27542823 |
Zager RA et al. | Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure. | 2016 | Kidney Int. | pmid:27165818 |
Montano-Pedroso JC et al. | Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. | 2016 | Trials | pmid:27068478 |
Han YM et al. | Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea. | 2016 | Gut Liver | pmid:27021505 |
Barbieri C et al. | Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients. | 2016 | PLoS ONE | pmid:26939055 |
Bitsi S et al. | Profound hyperglycemia in knockout mutant mice identifies novel function for POU4F2/Brn-3b in regulating metabolic processes. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:26670484 |
Nomoto H et al. | A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report. | 2017 | Medicine (Baltimore) | pmid:28953654 |
Deng Y et al. | Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study. | 2017 | Med. Sci. Monit. | pmid:28285317 |
Derman R et al. | A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. | 2017 | Am. J. Hematol. | pmid:28052413 |
Lee T et al. | Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. | 2017 | Gut | pmid:26848182 |